Neuronetics Inc expected to post a loss of 25 cents a share - Earnings Preview

Neuronetics

28/02/2025 14:18

Neuronetics Inc STIM.OQ STIM.O is expected to show a fall in quarterly revenue when it reports  results on March 4 for the period ending December 31 2024

The Malvern Pennsylvania-based  company is expected to report a 3.3% decrease in revenue to $19.634 million from $20.31 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on November 12 2024, for the period ended December 31, was for revenue between $19.00 million and $20.00 million.

​LSEG's mean analyst estimate for Neuronetics Inc is for a loss of 25 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Neuronetics Inc is $3.00​, below​ its last closing price of $4.28. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.23
-0.23
-0.44
Missed
-91.3
Jun. 30 2024
-0.27
-0.27
-0.33
Missed
-22.2
Mar. 31 2024
-0.32
-0.31
-0.27
Beat
12.9​
Dec. 31 2023
-0.26
-0.26
-0.19
Beat
27.3
​​Sep. 30 2023
-0.31
-0.31
-0.33
Missed
-6.7
Jun. 30 2023
-0.35
-0.35
-0.17
Beat
51.2​
Mar. 31 2023
-0.39
-0.39
-0.38
Beat
2.1
Dec. 31 2022
-0.35
-0.38
-0.30
Beat
21.3

This summary was machine generated February 28 at 14:18 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)